2018
DOI: 10.1016/j.brainres.2018.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Schwann cells protect against CaMKII- and PKA-dependent Acrylamide-induced Synapsin I phosphorylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…ERK phosphorylates mammalian synapsin I at positions 4 and 5 of domain B and at position 6 of domain D (57). In addition, PKA and CaMKII can also act by phosphorylating synapsin I (58). In this study, a decrease was observed in the level of p-synapsin Ia/b (Ser549) after CMB model creation.…”
Section: Discussionmentioning
confidence: 50%
“…ERK phosphorylates mammalian synapsin I at positions 4 and 5 of domain B and at position 6 of domain D (57). In addition, PKA and CaMKII can also act by phosphorylating synapsin I (58). In this study, a decrease was observed in the level of p-synapsin Ia/b (Ser549) after CMB model creation.…”
Section: Discussionmentioning
confidence: 50%
“…4 Subchronic exposure to acrylamide causes sensory, motor and autonomic dysfunctions such as ataxia, gait abnormalities, skeletal muscle weakness and numbness of hands and feet. 5,6 Given the exposure to acrylamide is inevitable, it is crucial to search new treatment strategies for the repair of acrylamide-induced nerve injury and functional reconstruction.…”
Section: Introductionmentioning
confidence: 99%